Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 301 - 320 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »
Reset 

Positive Phase 1 Results of AKCEA-TTR-LRx Presented at the Heart Failure Society of America Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Akcea Therapeutics, Inc.

Verrica Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for VP-102 for the Treatment of Molluscum Contagiosum

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Verrica Pharmaceuticals Inc.

Batavia Biosciences receives $6.5M grant to take next step towards polio-free world

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Batavia Biosciences

Anavex Life Sciences Announces Preliminary Clinical Efficacy Data of its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients with Rett Syndrome

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Anavex Life Sciences Corp.

Myriad Announces Research Collaboration with University of Leeds

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Myriad Genetics, Inc.

ProMIS Neurosciences Executive Chairman Eugene Williams to Speak on Panel at Fall Investor Summit

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  ProMIS Neurosciences, Inc.

VitalHub Announces Exercise of Warrants Led by Institutional Investors

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  VitalHub Corporation

Aptose to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Aptose Biosciences Inc.

Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Onconova Therapeutics, Inc.

Checkpoint Therapeutics Announces Data Presentation at the European Society for Medical Oncology (ESMO) Congress 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Checkpoint Therapeutics, Inc. | Checkpoint Surgical

Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Wave Life Sciences Ltd.

Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Kura Oncology, Inc.

Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare  Conference on October 3rd, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Eloxx Pharmaceuticals, Inc.

BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  BioRestorative Therapies, Inc.

BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  BioCardia, Inc.

iCAD Exhibiting New Updates and Enhanced Xoft Platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Tabula Rasa HealthCare’s DoseMe® Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Tabula Rasa HealthCare

Extendicare Announces September 2019 Dividend of C$0.04 per Share

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Fulgent Genetics Launches Picture Genetics, a Consumer-Initiated Genetic Testing Offering

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Fulgent Genetics

Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Allena Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15 16  17  18  19  20  21  22  23  24  25 »
to the top ↑